BCYC
Price
$3.87
Change
-$0.14 (-3.49%)
Updated
Oct 6, 11:02 AM (EDT)
Capitalization
259.67M
23 days until earnings call
Intraday BUY SELL Signals
NRXP
Price
$2.88
Change
+$0.01 (+0.35%)
Updated
Oct 6, 11:08 AM (EDT)
Capitalization
124.26M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs NRXP

BCYC vs NRXP Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. NRXP commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and NRXP is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BCYC vs NRXP: Fundamental Ratings
BCYC
NRXP
OUTLOOK RATING
1..100
7065
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8661
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
19n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (8) in the null industry is somewhat better than the same rating for NRXP (53). This means that BCYC’s stock grew somewhat faster than NRXP’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as NRXP (100). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as NRXP (100). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (61) in the null industry is in the same range as BCYC (86). This means that NRXP’s stock grew similarly to BCYC’s over the last 12 months.

NRXP's P/E Growth Rating (89) in the null industry is in the same range as BCYC (100). This means that NRXP’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCNRXP
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (BCYC: $4.01 vs. NRXP: $2.87)
Brand notoriety: BCYC and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 520% vs. NRXP: 77%
Market capitalization -- BCYC: $259.67M vs. NRXP: $124.26M
BCYC [@Biotechnology] is valued at $259.67M. NRXP’s [@Biotechnology] market capitalization is $124.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green while NRXP’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 6 TA indicator(s) are bullish while NRXP’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 6 bullish, 4 bearish.
  • NRXP’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than NRXP.

Price Growth

BCYC (@Biotechnology) experienced а +8.09% price change this week, while NRXP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.87%. For the same industry, the average monthly price growth was -14.47%, and the average quarterly price growth was -3.41%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

NRXP is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-2.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BCYC
Daily Signal:
Gain/Loss:
NRXP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
URTH208.551.02
+0.49%
iShares MSCI World ETF (URTH)
IVRA15.98N/A
N/A
Invesco Real Assets ESG ETF
GOAU42.91-0.06
-0.14%
U.S. Global GO GOLD and Precious Metal Miners ETF (GOAU)
WNTR14.60-0.25
-1.68%
YieldMax MSTR Short Option Income Strategy ETF
PFN6.19-0.15
-2.37%
PIMCO Income Strategy Fund II

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PCVX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+18.64%
PCVX - BCYC
47%
Loosely correlated
+30.70%
DNLI - BCYC
47%
Loosely correlated
-0.45%
NRIX - BCYC
46%
Loosely correlated
-0.48%
NGNE - BCYC
46%
Loosely correlated
+3.20%
EDIT - BCYC
45%
Loosely correlated
+6.49%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with TAOX. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
-1.20%
TAOX - NRXP
84%
Closely correlated
+0.45%
ALLR - NRXP
81%
Closely correlated
-3.85%
PALI - NRXP
74%
Closely correlated
+1.39%
BCYC - NRXP
34%
Loosely correlated
+18.64%
CRBU - NRXP
33%
Poorly correlated
-2.46%
More